Antiepileptic drugs market is anticipated to grow at a significant CAGR during the forecast period. Antiepileptic drugs (AEDs) are commonly known as anticonvulsants or antiseizure drugs. These drugs are used in the treatment of epileptic seizures. Epilepsy is a central neurological disorder that causes brain activity to become abnormal and further causes seizures or periods of unusual behaviour, sensations and sometimes loss of awareness. Additionally, these drugs are also used to stabilize the mood along with the treatment of bipolar disorders or neuropathic pain.
Some major key players in the market include Abbott Laboratories, GlaxoSmithKline plc, and Pfizer Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in January 2022, Sun Pharmaceutical Industries Ltd. announced the launch of a range of Brivaracetam dosage forms at an affordable price for epilepsy treatment in India. Additionally, in June 2021, Glenmark Pharma announced the launch of the anti-epileptic drug, Rufinamide tablets in the US market. Furthermore, in March 2021, Alkem Laboratories has announced the launch of Brivasure, an affordable anti-epileptic drug for the treatment of epilepsy in India.
To Request a Sample of our Report on Antiepileptic Drugs (AEDs) Market: https://www.omrglobal.com/request-sample/antiepileptic-drugs-aeds-market
Market Coverage
- The market number available for – 2021-2029
- Base year- 2021
- Forecast period- 2023-2029
Segment Covered-
- By Drug Type
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Abbott Laboratories, GlaxoSmithKline plc, and Pfizer Inc., among others.
Antiepileptic Drugs Market Report by Segment
By Drug Type
- First Generation AEDs
- Phenytoin (Dilantin, Phenytek)
- Carbamazepine (Carbatrol)
- Oxycarbazepine (Trileptal)
- Valproate (Depakote)
- Others
Second Generation AEDs
- Lamotrigine (Lamictal)
- Pregabalin (Lyrica)
- Rufinamide (Banzel/Inovelon)
- Levetiracetam (Keppra)
- Others
A full Report Antiepileptic Drugs (AEDs) Market is Available @ https://www.omrglobal.com/industry-reports/antiepileptic-drugs-aeds-market
Antiepileptic Drugs Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/antiepileptic-drugs-aeds-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
